• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    29.78 Up 0.48(1.64%) 4:00PM EST
    |After Hours : 29.51 Down 0.27 (0.91%) 7:25PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 3,586   4,111   11,202  
    Cost of Revenue -   -   -  
    Gross Profit 3,586   4,111   11,202  
    Operating Expenses
    Research Development104,381  67,401  47,398  
    Selling General and Administrative20,622  14,805  10,016  
    Non Recurring -  2,334  10,775  
    Others1,013  1,013  1,090  
    Total Operating Expenses -  85,553  69,279  
    Operating Income or Loss (122,430) (81,442) (58,077)
    Income from Continuing Operations
    Total Other Income/Expenses Net4,350  819  530  
    Earnings Before Interest And Taxes(118,080)(80,623)(57,547)
    Interest Expense -  927  1,576  
    Income Before Tax(118,080)(81,550)(59,123)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(118,080)(81,550)(59,123)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (118,080) (81,550) (59,123)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (118,080) (81,550) (59,123)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.